Buprenorphine and Medication Assisted Treatment (MAT) Train the Trainer (TTT) Program

Apply Today »

The Buprenorphine and MAT TTT Program is a two-day training hosted in Washington, D.C., that offers an in-depth training to DEA-X waivered psychiatrists who are currently prescribing buprenorphine to patients and are interested in serving as a regional buprenorphine trainer.

The program, hosted in partnership by APA and Providers Clinical Support System (PCSS) aims to expand the network of local buprenorphine trainers nation-wide, increase the number of buprenorphine trainings and expand the number of buprenorphine-waivered providers to increase access to MAT.

2019 Program Details:

  • June 9-10, 2019
  • APA Headquarters, Washington, D.C.
  • Application Deadline: April 26, 2019

There is no fee to apply or participate in the program. APA will provide travel and accommodations for all program participants in accordance with APA travel policies.

Eligibility & Application Requirements

Who is eligible to participate in the Buprenorphine and MAT TTT program?

To participate in the program, participants must meet the following criteria:
  • Must be committed to serving as a buprenorphine trainer in their region
  • Must already have a DEA X-license to prescribe buprenorphine
  • Must have a history of prescribing buprenorphine (two or more years)
  • Must receive a letter of support from district branch

If you have received your Buprenorphine waiver within the past two years (between April 2017 to present), you are not eligible to participate in this program.

Why must I receive a letter of support from my district branch? What must be included in my letter?

This letter serves as confirmation that you have received support from your branch to coordinate and carry out trainings at the regional level. This letter should include a detailed plan outlining when and where your first Buprenorphine waiver training will occur and how the training will be funded.

Participants are expected to secure funding for trainings as financial support will not be provided. We encourage participants to collaborate with their district branch, as there may be an opportunity to host a training as part of a state-wide or regional meeting. Additional strategies to fund your Buprenorphine training include, but are not limited to, charging tuition or a small fee to attendees or partnering with local health departments to utilize available state funding.

How can I contact my district branch executive?

Contact information for all district branch executives can be found on the APA's District Branch Directory page.

How are program participants selected?

The select process is blind and conducted by a number of medication assisted treatment experts.

Will continuing medical education credits be offered?

The APA is accredited by the Accreditation Council for Continuing Medical Education (CME) to provide continuing medical education for physicians. 8 CME credits will be offered for the completion of the program.

What resources will be made available to me as a trainer?

Participants are provided the Buprenorphine waiver curriculum, standardized course materials, marketing copy, and CME resources.

 

Questions?

Contact Rachel Trusty at rtrusty@psych.org for more information on the Buprenorphine and MAT TTT Program.

 
Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.